BAC vs ECPG: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: ECPG is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. BAC and ECPG share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined BAC and ECPG exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Bank of America is the second-largest US bank by assets, behind JPMorgan Chase. The company is one of the four mega-bank holding companies (along with JPMorgan, Citigroup, and Wells Fargo) and operates across four main reporting segments. Consumer Banking is the largest retail bank in the US by deposits, serving over 60 million customers through ~3,800 branches. Global Wealth and Investment Management is one of the largest US wealth managers (anchored by Merrill Lynch). Global Banking provides commercial banking, treasury services, and investment banking to corporate and institutional clients. Global Markets provides trading services across fixed income, equities, and commodities.

Full BAC guide

Encore Capital Group is one of the two largest publicly traded buyers of charged-off consumer receivables. When a bank or card issuer gives up on a delinquent account, it sells the paper for cents on the dollar, and Encore is one of the buyers. In the United States it collects through Midland Credit Management (MCM), which handles credit card and consumer loan paper; in Europe, mainly the United Kingdom, it operates as Cabot Credit Management, which buys both unsecured consumer debt and some secured and semi-performing portfolios. The business has three moving parts: how much paper Encore buys and at what price, how much cash it eventually collects against that price, and how cheaply it can fund the balance sheet in between. It reported ~$443.8 million of global portfolio purchases in the second quarter of 2026, split ~$372.3 million in the U.S. (a record) and ~$71.5 million in Europe, and collected ~$736.9 million globally in the same quarter.

Full ECPG guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• BAC drivers: Net interest income from deposit franchise; Investment banking and trading recovery.
• ECPG drivers: Supply and purchase pricing in the U.S; Collections converting into recognized revenue.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Credit quality is the eternal bank risk; consumer and commercial credit losses cyclically. For ECPG, the largest single risk is that ERC is a management estimate of cash to be collected over more than a decade, and a downward revision hits both the balance sheet and reported revenue at once, as the ~$101 million goodwill charge attached to weak European results in early 2025 illustrated.

Pick BAC if you believe its drivers more; ECPG if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the BAC and ECPG guides.

BAC. BAC trades at a modest P/E typical of large US banks. The valuation balances the durable consumer deposit franchise and capital markets recovery against credit cycle uncertainty and regulatory capital requirements. Price-to-book around 1.1x is consistent with ROE around 10%.

ECPG. Q2 2026 produced revenue of ~$491.9 million (up ~11%), GAAP net income of ~$64.0 million and diluted EPS of ~$2.81, which included roughly $1.00 per share of costs from the $1 billion refinancing. First-half diluted EPS was ~$6.66 on ~$967.3 million of revenue. Management raised the 2026 collections forecast to ~$2.80 billion to ~$2.85 billion and guided EPS to ~$13.00 to ~$14.00, which puts the ~$97.50 share price near seven times guided earnings. That multiple is low relative to the broader market for a reason: the earnings depend on multi-year collection estimates and are levered on ~$4.18 billion of debt.

Headline figures (approximate, early 2026): BAC shows revenue (ttm) ~$100 billion, net income (ttm) ~$28 billion, eps (ttm) ~$3.50, p/e (ttm) ~13x; ECPG shows revenue (ttm) ~$1.90B, global collections (q2 2026) ~$737M, diluted eps (q2 2026) ~$2.81, 2026 eps guidance ~$13.00 to ~$14.00.

BAC and ECPG are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined BAC and ECPG exposure against your real portfolio. It is not an investment adviser.